ARCHIVES

PV-10 Produces 51 Percent Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Congress Approves Payments For Treatment Of Women Diagnosed In CDC Program.

October 13, 2000

NCAB Accepts Report, Seeks Comment From Researchers, Patient Groups

May 19, 1995

House Appropriations Adds $20 Mil. To Bush Request For NCI, Emphasizes Three Cancers

June 28, 1991

Sense Of Excitement, Challenges, Mark Healy’s Debut

April 26, 1991

An Appreciation: Eddie Reed, 60, a Developer of Taxol

June 6, 2014

INSPIRE Enrollment Stopped; Thromboembolism Risk Cited

February 25, 2011